Can Epstein-Barr virus (EBV) cause diarrhea?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can EBV Cause Diarrhea?

Yes, Epstein-Barr virus (EBV) can cause diarrhea, though this is uncommon and typically occurs in specific clinical contexts: chronic active EBV infection (CAEBV) with gastrointestinal involvement, or in immunocompromised patients.

Clinical Context and Recognition

EBV is not listed among the typical infectious causes of diarrhea in major infectious disease guidelines 1, 2. The 2017 IDSA guidelines for infectious diarrhea extensively detail bacterial, viral (norovirus, rotavirus, enteroviruses), and parasitic causes but do not mention EBV as a common diarrheal pathogen 1, 2. However, this does not mean EBV cannot cause diarrhea—it simply reflects that it is rare enough not to warrant routine consideration in typical acute diarrheal illness.

When EBV Does Cause Diarrhea

In immunocompromised patients: The IDSA guidelines specifically mention that immunocompromised patients with diarrhea should be evaluated for CMV (cytomegalovirus, another herpesvirus) 1, 2, and guidelines on immunocompromised patients note EBV can cause gastrointestinal disease in this population 3, 4.

In chronic active EBV infection (CAEBV): This is where the strongest evidence exists. Recent case series demonstrate that CAEBV can present with gastrointestinal involvement, including diarrhea:

  • Diarrhea is a common presenting symptom in CAEBV with GI involvement, occurring in 50-87% of cases 5, 6, 7
  • The most common site is the colon, followed by gastric involvement 8, 5, 9
  • Clinical presentation mimics inflammatory bowel disease (IBD), with intermittent fever (100% of cases), diarrhea, hematochezia, and abdominal pain 8, 6

Diagnostic Approach When Suspecting EBV-Related Diarrhea

Look for these specific red flags that distinguish EBV colitis from typical infectious diarrhea or IBD:

Key Clinical Features

  • Intermittent fever (present in 100% of CAEBV cases) 6
  • Systemic manifestations: hepatosplenomegaly (58%), lymphadenopathy (50%) 6
  • Markedly elevated ferritin (significantly higher than in IBD patients) 6
  • Recurrent or chronic course over months to years 8

Laboratory Findings

  • Extremely high EBV DNA viral load in peripheral blood: median 1.42×10⁶ copies/μg in CAEBV versus 3.2×10³ copies/μg in IBD patients with incidental EBV positivity 6
  • Elevated liver enzymes (ALT, AST) 5
  • Low natural killer cell activity 5

Endoscopic Findings

  • Multiple irregular, multiform ulcers (not the typical cobblestone pattern of Crohn's disease) 6
  • Diffuse inflammation, hyperemia, and edema 5, 7
  • Can involve colon, gastric antrum, or esophagus 5, 7

Definitive Diagnosis

  • Tissue biopsy with EBER (EBV-encoded RNA) in situ hybridization showing positive staining in intestinal tissue 8, 5, 9, 6
  • Identification of infected T-cell or NK-cell lineage 9

Critical Pitfall: Misdiagnosis as IBD

The most common diagnostic error is misdiagnosing CAEBV colitis as inflammatory bowel disease 8, 6, 7. This leads to inappropriate immunosuppressive therapy (mesalazine, corticosteroids) that may temporarily improve symptoms but fails to address the underlying EBV infection and can worsen outcomes 8.

How to Avoid This Pitfall

  • In any patient with "IBD-like" symptoms plus intermittent fever and systemic manifestations, check EBV DNA viral load
  • If EBV DNA is markedly elevated (>10⁵ copies), perform colonoscopy with biopsy for EBER in situ hybridization
  • Do not assume positive EBV serology or low-level viremia is incidental—quantitative viral load matters

Prognosis and Urgency

CAEBV with gastrointestinal involvement has a poor prognosis with 3-year survival of only 59.3% compared to 79.4% in CAEBV without GI involvement 5. Average survival is 21 months without definitive treatment 6. Complications include:

  • Intestinal perforation and necrotizing enterocolitis 5
  • Progression to EBV-associated lymphoproliferative disorders or lymphoma 10, 11
  • Hemophagocytic lymphohistiocytosis 12

Treatment Considerations

While detailed treatment protocols are beyond the scope of this question, recognize that:

  • Hematopoietic stem cell transplantation is the only curative treatment 9, 11
  • Immunosuppressive therapy alone (as used for IBD) is inadequate and potentially harmful 8
  • Antiviral therapy (acyclovir, ganciclovir) and immunomodulation (rituximab, corticosteroids) may provide temporary benefit but are not curative 8, 9

Bottom Line for Clinical Practice

EBV should be considered as a cause of diarrhea when:

  1. Diarrhea is chronic or recurrent with systemic symptoms (fever, hepatosplenomegaly, lymphadenopathy)
  2. Patient is immunocompromised (transplant recipient, on immunosuppression, HIV/AIDS)
  3. Endoscopic findings suggest IBD but patient has prominent fever and elevated ferritin
  4. Initial IBD treatment provides only partial or temporary relief

In these scenarios, obtain quantitative EBV DNA viral load and, if markedly elevated, proceed to colonoscopy with EBER in situ hybridization of tissue biopsies 6, 13.

References

Research

[Liver and colonic manifestation of active chronic infection by Epstein Barr virus].

Andes pediatrica : revista Chilena de pediatria, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.